Literature DB >> 16832083

Quality improvement in acute stroke: the New York State Stroke Center Designation Project.

T I Gropen1, P J Gagliano, C A Blake, R L Sacco, T Kwiatkowski, N J Richmond, D Leifer, R Libman, S Azhar, M B Daley.   

Abstract

BACKGROUND: Many hospitals lack the infrastructure required to treat patients with acute stroke. The Brain Attack Coalition (BAC) published guidelines for the establishment of primary stroke centers.
OBJECTIVE: To determine if stroke center designation and selective triage of acute stroke patients improve quality of care.
METHODS: Baseline chart abstraction was performed on all stroke patients admitted to 32 hospitals serving Brooklyn and Queens, NY, from March to May 2002. Hospitals were invited to meet BAC guideline-based criteria. Adherence was verified by on-site visits. After designation, acute stroke patients were selectively triaged. Remeasurement data were collected from August to October 2003.
RESULTS: The authors abstracted 1,598 charts at baseline and 1,442 charts at remeasurement. From baseline to remeasurement, median times decreased for door to physician contact (25 vs 15 minutes, p = 0.001), CT performance for potential tissue plasminogen activator (t-PA) candidates (68 vs 32 minutes, p < 0.001), and t-PA administration (109 vs 98 minutes (p = NS). IV t-PA utilization increased from 2.4 to 5.2% (p < 0.005), select t-PA protocol violations decreased from 11.1 to 7.9% (p = NS), and the stroke unit admission rate increased from 16 to 39% (p < 0.001). In stroke centers (n = 14) vs nondesignated hospitals (n = 18), there were shorter median times from door to physician contact (10 vs 25 minutes, p < 0.001), CT performance for potential t-PA candidates (31 vs 40 minutes, p = NS), and t-PA administration (95 vs 115 minutes, p < 0.05). Stroke centers, compared with nondesignated centers, admitted acute stroke patients to stroke units more often (55.9 vs 10.9%, p < 0.001).
CONCLUSIONS: Stroke center designation and selective triage of acute stroke patients improved the quality of care, including access to timely thrombolytic therapy and stroke units.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832083     DOI: 10.1212/01.wnl.0000223622.13641.6d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Growth of regional acute stroke systems of care in the United States in the first decade of the 21st century.

Authors:  Sarah Song; Jeffrey Saver
Journal:  Stroke       Date:  2012-06-05       Impact factor: 7.914

2.  Advances in the stroke system of care.

Authors:  Matthew L Clark; Toby Gropen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

3.  Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

Authors:  Natalia S Rost; Eric E Smith; Muhammad A Pervez; Philip Mello; Paul Dreyer; Lee H Schwamm
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-24

4.  Camera in the emergency department: the evolution of stroke telemedicine.

Authors:  James F Meschia
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

5.  Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers.

Authors:  J H Lichtman; S B Jones; Y Wang; E Watanabe; E Leifheit-Limson; L B Goldstein
Journal:  Neurology       Date:  2011-05-04       Impact factor: 9.910

6.  Methylene Blue Reduces Acute Cerebral Ischemic Injury via the Induction of Mitophagy.

Authors:  Yao Di; Yun-Ling He; Tong Zhao; Xin Huang; Kui-Wu Wu; Shu-Hong Liu; Yong-Qi Zhao; Ming Fan; Li-Ying Wu; Ling-Ling Zhu
Journal:  Mol Med       Date:  2015-05-19       Impact factor: 6.354

7.  30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals.

Authors:  Judith H Lichtman; Sara B Jones; Erica C Leifheit-Limson; Yun Wang; Larry B Goldstein
Journal:  Stroke       Date:  2011-10-27       Impact factor: 7.914

8.  Ginsenoside rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic window.

Authors:  Ruidong Ye; Xiangwei Kong; Qianzi Yang; Yunxia Zhang; Junliang Han; Ping Li; Lize Xiong; Gang Zhao
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

9.  Emergency transport of stroke suspects in a rural state: opportunities for improvement.

Authors:  Aliza T Brown; Feifei Wei; William C Culp; Greg Brown; Ryan Tyler; Appathurai Balamurugan; Nicolas Bianchi
Journal:  Am J Emerg Med       Date:  2016-06-14       Impact factor: 2.469

Review 10.  The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models.

Authors:  Maarten M H Lahr; Gert-Jan Luijckx; Patrick C A J Vroomen; Durk-Jouke van der Zee; Erik Buskens
Journal:  J Neurol       Date:  2012-08-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.